Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F De Vos

Showing results (251-260 of 263) with videos related to

Pageof 27
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|July 11, 2018
Role of Peptidylarginine Deiminase 4 in Neutrophil Extracellular Trap Formation and Host Defense during <i>Klebsiella pneumoniae-</i>Induced Pneumonia-Derived SepsisTheodora A M Claushuis, Lieve E H van der Donk, Anna L Luitse, et al.
The Lancet. Oncology|August 18, 2018
Bevacizumab and temozolomide in patients with first recurrence of WHO grade II and III glioma, without 1p/19q co-deletion (TAVAREC): a randomised controlled phase 2 EORTC trialMartin J van den Bent, Martin Klein, Marion Smits, et al.
Plos Pathogens|May 23, 2009
The urokinase receptor (uPAR) facilitates clearance of Borrelia burgdorferiJoppe W R Hovius, Maarten F Bijlsma, Gerritje J W van der Windt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 28, 2022
Infigratinib in Patients with Recurrent Gliomas and FGFR Alterations: A Multicenter Phase II StudyAndrew B Lassman, Juan Manuel Sepúlveda-Sánchez, Timothy F Cloughesy, et al.
Ejhaem|July 18, 2022
Comparison of inhibitory effects of irreversible and reversible Btk inhibitors on platelet functionBibian M E Tullemans, Mieke F A Karel, Valentine Léopold, et al.
Tuberculosis (Edinburgh, Scotland)|July 10, 2015
Increased intra- and extracellular granzyme expression in patients with tuberculosisM Isabel Garcia-Laorden, Dana C Blok, Liesbeth M Kager, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 16, 2022
Prognostic Significance of DNA Methylation Profiles at MRI Enhancing Tumor Recurrence: a Report from the EORTC 26091 TAVAREC TrialKaspar Draaisma, C Mircea S Tesileanu, Iris de Heer, et al.
Nature Communications|September 29, 2025
Effect of the gut microbiota-derived tryptophan metabolite indole-3-acetic acid in pneumoniaRobert F J Kullberg, Christine C A van Linge, Bastiaan W Haak, et al.
BMC Medical Genomics|November 5, 2022
Study protocol of the GLOW study: maximising treatment options for recurrent glioblastoma patients by whole genome sequencing-based diagnostics-a prospective multicenter cohort studyMark P van Opijnen, Marike L D Broekman, Filip Y F de Vos, et al.
BMC Infectious Diseases|April 19, 2015
Expression of inhibitory regulators of innate immunity in patients with active tuberculosisDana C Blok, Liesbeth M Kager, Arie J Hoogendijk, et al.
Pageof 27

Showing results (251-260 of 263) with videos related to

Sort By:
Pageof 27
Journal of Immunology (Baltimore, Md. : 1950)|July 11, 2018
Role of Peptidylarginine Deiminase 4 in Neutrophil Extracellular Trap Formation and Host Defense during <i>Klebsiella pneumoniae-</i>Induced Pneumonia-Derived SepsisTheodora A M Claushuis, Lieve E H van der Donk, Anna L Luitse, et al.
The Lancet. Oncology|August 18, 2018
Bevacizumab and temozolomide in patients with first recurrence of WHO grade II and III glioma, without 1p/19q co-deletion (TAVAREC): a randomised controlled phase 2 EORTC trialMartin J van den Bent, Martin Klein, Marion Smits, et al.
Plos Pathogens|May 23, 2009
The urokinase receptor (uPAR) facilitates clearance of Borrelia burgdorferiJoppe W R Hovius, Maarten F Bijlsma, Gerritje J W van der Windt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 28, 2022
Infigratinib in Patients with Recurrent Gliomas and FGFR Alterations: A Multicenter Phase II StudyAndrew B Lassman, Juan Manuel Sepúlveda-Sánchez, Timothy F Cloughesy, et al.
Ejhaem|July 18, 2022
Comparison of inhibitory effects of irreversible and reversible Btk inhibitors on platelet functionBibian M E Tullemans, Mieke F A Karel, Valentine Léopold, et al.
Tuberculosis (Edinburgh, Scotland)|July 10, 2015
Increased intra- and extracellular granzyme expression in patients with tuberculosisM Isabel Garcia-Laorden, Dana C Blok, Liesbeth M Kager, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 16, 2022
Prognostic Significance of DNA Methylation Profiles at MRI Enhancing Tumor Recurrence: a Report from the EORTC 26091 TAVAREC TrialKaspar Draaisma, C Mircea S Tesileanu, Iris de Heer, et al.
Nature Communications|September 29, 2025
Effect of the gut microbiota-derived tryptophan metabolite indole-3-acetic acid in pneumoniaRobert F J Kullberg, Christine C A van Linge, Bastiaan W Haak, et al.
BMC Medical Genomics|November 5, 2022
Study protocol of the GLOW study: maximising treatment options for recurrent glioblastoma patients by whole genome sequencing-based diagnostics-a prospective multicenter cohort studyMark P van Opijnen, Marike L D Broekman, Filip Y F de Vos, et al.
BMC Infectious Diseases|April 19, 2015
Expression of inhibitory regulators of innate immunity in patients with active tuberculosisDana C Blok, Liesbeth M Kager, Arie J Hoogendijk, et al.
Pageof 27